Zhou Liu Fu Jewellery Co. Ltd. (6168 HK) is a Chinese company specializing in jewelry retail, with a network of over 4,100 stores. Zhou Liu Fu Jewellery plans to list on the Hong Kong Stock Exchange on June 26, 2025. The company is offering 46.8 million primary shares at a fixed price of HK$24.00 each to raise approximately HK$1.12 billion (USD 143 million). According to the company, half of the proceeds will be used for sales network expansion and reinforcement. The remainder will reportedly be allocated to brand enhancement (20%), improving product design capabilities (20%), and general working capital (10%). The offering consists entirely of new shares.

Eternal Beauty Holdings Ltd (6883 HK) is a Hong Kong-based company specializing in perfume distribution and brand management. Eternal Beauty plans to list on the Hong Kong Stock Exchange on June 26, 2025. The company is offering 333.4 million primary shares with a price range of HK$2.80 to HK$3.38 apiece, aiming to raise up to HK$1.13 billion (approx. USD 143.55 million). According to reports, Eternal Beauty is the largest perfume brand management company in China, including the mainland, Hong Kong, and Macau, based on 2023 retail sales. Its distribution portfolio includes luxury brands such as Hermes, Van Cleef & Arpels, and Coach. The IPO consists entirely of new shares.

Jefferson Capital Inc. (JCAP US) is a United States company specializing in the acquisition and management of distressed consumer debt, such as charged-off credit card balances and auto loans across the Americas and the U.K. Jefferson Capital plans to list on the NASDAQ Global Select Market on June 26, 2025. The company and its stockholders are offering 10.0 million shares within a price range of $15.00 to $17.00 each, aiming to raise up to $170 million. The IPO is primarily a secondary offering, with existing investors selling 9.38 million shares and the company offering just 625,000. Consequently, the vast majority of proceeds will go to the selling stockholders, not the company.

Saint Bella Inc. (2508 HK) is a leading Chinese postpartum care and recovery group, reportedly the largest in Asia by revenue from its centers. The company plans to list on the Hong Kong Stock Exchange on June 26, 2025. It is offering 95.42 million primary shares at a fixed price of HK$6.58 each to raise HK$627.86 million (approx. USD 79.98 million). Saint Bella operates a network of 96 premium postpartum centers under the Saint Bella, Bella Isla, and Baby Bella brands across China, Hong Kong, Singapore, and the U.S. According to reports, the company intends to use the IPO proceeds to expand its service network, strengthen brand recognition, upgrade IT systems, and for general working capital.

Unisound AI Technology Co Ltd (9678 HK) is a China-domiciled company specializing in conversational AI products and solutions for daily life and healthcare. The company's technology is centered around its proprietary UniBrain platform and its large language model, UniGPT. Unisound AI Technology plans to list on the Hong Kong Stock Exchange on June 30, 2025. The company intends to offer 1.56 million shares at a price range of HKD 165.00 to HKD 205.00, aiming to raise approximately HKD 320 million (USD 40.76 million). Proceeds from the IPO will reportedly be used to scale its Atlas AI infrastructure, fund R&D, pursue international expansion, and invest in new verticals and strategic partnerships.

Rent Corp (372A JP) is a Japanese company specializing in the rental of equipment and vehicles for various industries, including construction, transportation, and on-site office support. Rent Corp plans to list on the Tokyo Stock Exchange on June 30, 2025, offering 844,000 shares at a price of JPY 4,330. The IPO is expected to raise approximately JPY 3.65 billion ($25.31 million), giving the company a market capitalization of JPY 16.28 billion ($112.74 million) at the offer price. The offering consists of a mix of primary (59.24%) and secondary (40.76%) shares, meaning proceeds will go to both the company and selling shareholders. The offering, which is managed by Mizuho Securities Co Ltd, also includes a greenshoe option for an additional 126,600 shares.

Medtide Inc. (3880 HK) is a China-domiciled, peptide-focused contract research, development, and manufacturing organization (CRDMO). It provides full-cycle services from early-stage discovery to commercial-stage production of peptide APIs, with a strategic focus on the high-growth GLP-1 drug market. Medtide plans to list on the Hong Kong Stock Exchange on June 30, 2025, offering 16.8 million shares priced between HKD 28.40 and HKD 30.60. The company expects to raise up to HKD 514.08 million (USD 65.49 million). According to reports, the proceeds will be used primarily to expand manufacturing capacity and enhance R&D capabilities, with the remainder allocated to working capital and general corporate purposes.

IFBH Ltd (6603 HK) is a Thailand-based company specializing in ready-to-consume beverages, such as coconut water and fruit juice-based drinks. A spin-off from the international business of General Beverage, IFBH focuses on the if and Innococo brands in markets outside of Thailand. The company plans to list on the Hong Kong Stock Exchange on June 30, 2025. It is offering 41.67 million shares, priced between HKD 25.30 and HKD 27.80. The IPO aims to raise approximately HKD 1.16 billion (USD 147.56 million). IFBH Ltd reportedly plans to use the proceeds for research and development, brand promotion and business development, as well as for working capital and strategic acquisitions.

Cloudbreak Pharma Inc. (Ticker: 2592 HK) is a Hong Kong-based, clinical-stage ophthalmology biotechnology company focusing on the development of treatments for eye diseases. Cloudbreak Pharma plans to list on the Hong Kong Stock Exchange on July 3, 2025, offering 60.58 million shares at HKD 10.10 to raise HKD 611.88 million (approximately $77.95 million). The company's market capitalization at the time of the offer is reportedly $1.08 billion. According to company documents, proceeds from the offering will likely be used to fund the ongoing clinical trials for its core products, CBT-001 for pterygium and CBT-009 for juvenile myopia, and to advance its pipeline of other clinical and pre-clinical drug candidates.

Anjoy Foods Group Co Ltd (Ticker: 2648 HK) is a Chinese company specializing in the manufacturing and distribution of quick-frozen food products, including processed items, prepared dishes, and flour and rice products. Anjoy Foods Group plans to list on the Hong Kong Stock Exchange on July 4, 2025, offering 39.99 million shares at HKD 66.00 each to raise HKD 2.64 billion (approximately $336.3 million). The IPO reportedly gives the company a market capitalization of around $2.8 billion. While a specific use of proceeds was not detailed, funds from an IPO are typically used for purposes such as expanding production capacity, strengthening distribution networks, brand development, and general corporate purposes.

FWD Group (Ticker: 1828 HK) is a Hong Kong-based Pan-Asian life insurance company with a customer-led and technology-enabled model operating across ten markets. FWD Group plans to list on the Hong Kong Stock Exchange on July 7, 2025, planning to offer 91.3 million shares at HK$38.00 apiece, raising HK$3.47 billion ($442.08 million). The deal values the insurer at approximately $6.15 billion. The company reportedly plans to use the IPO proceeds to improve its capital position, reduce debt, and grow its customer base and digital strategies. This is the insurer's third attempt at an IPO, with cornerstone investors including Abu Dhabi's Mubadala Capital and a subsidiary of Japan's T&D Holdings.